PRF Technologies (PRFX) Net Cash Flow (2020 - 2024)
PRF Technologies (PRFX) posted quarterly Net Cash Flow of $3.5 million for Q2 2024, up 217.38% year-on-year from $1.1 million in Q3 2023, and up 195.22% on a QoQ basis from -$3.7 million in Q1 2024.
PRF Technologies (PRFX) Net Cash Flow (2020 - 2024) Analysis & Trends
PRF Technologies (PRFX) has reported Net Cash Flow for 5 consecutive years, with $3.5 million the latest figure, recorded in Q2 2024.
- Quarterly Net Cash Flow rose 217.38% year-over-year to $3.5 million in Q2 2024, while the trailing twelve-month figure through Dec 2025 was $3.5 million (up 1107.19% YoY) and the FY2025 annual result came in at -$1.1 million, up 70.33% from the prior year.
- Net Cash Flow climbed to $3.5 million in Q2 2024 per PRFX's latest filing, from -$3.7 million in the prior quarter.
- Over the last five years, Net Cash Flow for PRFX reached as high as $2.7 billion in Q3 2021 and fell as low as -$2.7 billion in Q4 2021.
- A 5-year average of $389166.7 and a median of -$661500.0 in 2020 frame the typical range for Net Cash Flow.
- The largest YoY upside for Net Cash Flow was 15493.58% in 2021 against a maximum downside of 132332.97% in 2021.
- Year by year, Net Cash Flow stood at -$2.0 million in 2020, then tumbled by 132332.97% to -$2.7 billion in 2021, then surged by 99.89% to -$2.8 million in 2022, then soared by 116.51% to $469000.0 in 2023, then soared by 651.6% to $3.5 million in 2024.
- According to Business Quant data, Net Cash Flow over the past three periods registered $3.5 million, -$3.7 million, and $469000.0 for Q2 2024, Q1 2024, and Q4 2023 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 202.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -526.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 711.50 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -277.40 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 461.90 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -446.50 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -112.00 Mn |
| 10 | PRF Technologies | 745,168.93 | 451,168.93 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 3.53 Mn |
| Jun 30, 2024 | 3.53 Mn |
| Mar 31, 2024 | -3.70 Mn |
| Mar 31, 2024 | -3.70 Mn |
| Dec 31, 2023 | 469,000.00 |
| Dec 31, 2023 | 469,000.00 |
| Sep 30, 2023 | 2.41 Mn |
| Sep 30, 2023 | 2.41 Mn |
| Jun 30, 2023 | -3.00 Mn |
| Jun 30, 2023 | -3.00 Mn |
| Mar 31, 2023 | 4.05 Mn |
| Mar 31, 2023 | 4.05 Mn |
| Dec 31, 2022 | -2.84 Mn |
| Dec 31, 2022 | -2.84 Mn |
| Sep 30, 2022 | -6.92 Mn |
| Sep 30, 2022 | -6.92 Mn |
| Jun 30, 2022 | -1.59 Mn |
| Jun 30, 2022 | -1.59 Mn |
| Mar 31, 2022 | -1.11 Mn |
| Mar 31, 2022 | -1.11 Mn |